Synergy of mycophenolate mofetil and bioflavonoids in prevention of immune and ischemic injury.
Shoskes
D A
DA
Harbor-UCLA Medical Center, Division of Urology, Torrance, California 90502, USA.
Jones
E A
EA
Shahed
A
A
D000818:Animals; D003474:Curcumin / Q000494:pharmacology; D004357:Drug Synergism; D005419:Flavonoids / Q000494:pharmacology*; D006084:Graft Rejection / Q000517:prevention & control*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007511:Ischemia; D007668:Kidney / Q000098:blood supply*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D011794:Quercetin / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000517:prevention & control*; D016038:Skin Transplantation / Q000276:immunology*
D005419:Flavonoids; D007166:Immunosuppressive Agents; D011794:Quercetin; D009173:Mycophenolic Acid; D003474:Curcumin